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Events in Patients With Chronic Myocardial
Infarction by Contrast-Enhanced CMR
Philipp Boyé, MD,*† Hassan Abdel-Aty, MD,*¶ Udo Zacharzowsky, MD,†
Steffen Bohl, MD,* Carsten Schwenke, PHD, Rob J. van der Geest, PHD,#
Rainer Dietz, MD,‡ Alexander Schirdewan, MD,§ Jeanette Schulz-Menger, MD*†
Berlin, Germany; and Leiden, the Netherlands
O B J E C T I V E S We hypothesized that infarct transmurality assessed with late gadolinium enhance-
ment cardiac magnetic resonance (LGE-CMR) predicts arrhythmic events in patients with chronic
myocardial infarction.
B A C KG ROUND Patients with decreased left ventricular function due to chronic myocardial
infarction are at increased risk for life-threatening arrhythmias related to infarcted tissue. LGE-CMR
accurately detects infarct morphology.
METHOD S We prospectively enrolled 52 patients with chronic myocardial infarction referred for
primary preventive implantable cardioverter-deﬁbrillator (ICD) implantation following MADIT (Multi-
center Automatic Deﬁbrillator Implantation Trial) study criteria. Using LGE-CMR, left ventricular volumes,
function, and infarct morphology were assessed including calculation of total and relative infarct mass,
infarct border, infarct border zone, and infarct transmurality.
R E S U L T S Patients were followed for 1,235  341 days. The primary combined endpoint
including appropriate device therapy (ICD discharge or antitachycardia pacing) or death from
cardiac cause occurred in 16 individuals resulting in an annual event rate of 4.7%. Six patients
received an appropriate shock, 7 patients received recurrent appropriate antitachycardia pacing for
sustained ventricular tachycardia, and 3 patients died of cardiac cause. There was a signiﬁcant
association to relative infarct mass (38  8% vs. 28  14%, p  0.02), infarct transmurality (24 
8 g vs. 16  12 g, p  0.02), and relative infarct transmurality (RIT) (63  12% vs. 48  23%, p 
0.01). In separate logistic regression models, no variable emerged as signiﬁcant when combined
with RIT. As a single effect, RIT emerged as a predictor of the primary endpoint (p  0.02). A RIT
cutoff at 43% resulted in a sensitivity of 88%, a speciﬁcity of 50%, a positive predictive value of 44%,
and a negative predictive value of 90%.
CONC L U S I O N S In patients with chronic myocardial infarction scheduled for primary preventive
ICD implantation, infarct transmurality as deﬁned by LGE-CMR identiﬁes a subgroup with increased risk
for life-threatening arrhythmias and cardiac death. (J Am Coll Cardiol Img 2011;4:871–9) © 2011 by the
American College of Cardiology Foundation
From the *Working Group Cardiac MRI, Charité Campus Buch, Experimental and Clinical Research Centre (ECRC),
Medical University Berlin, Berlin, Germany; †Clinic for Cardiology and Nephrology, HELIOS Klinikum Berlin-Buch, Berlin,
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VT ventricular tachycardia
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872pontaneous ventricular arrhythmias are con-
sidered to be critically involved in the patho-
physiology of sudden cardiac death (1), one
of the leading causes of mortality world-
wide, causing an estimated 184,000 to 462,000
deaths/year in the United States alone (2). In
particular, patients with heart failure due to a
previous myocardial infarction are at very high risk
with an annual sudden cardiac death rate of 4% to
7% (3). Insertion of implantable cardioverter-
defibrillators (ICDs) as primary preventive therapy
in this patient population was shown to significantly
reduce mortality when compared with standard
medical therapy (4–6). Although of proven efficacy,
ICD therapy is associated with survival benefit in
only a small fraction of patients. Specifically, it has
been estimated that to save 1 life, 18 patients would
have to get an ICD inserted, resulting in
an enormous burden on national health
systems (4). Moreover, only approximately
one-third of these patients receive ade-
quate therapy from the ICD within 3 years
after implantation (7). Furthermore, de-
spite considerable improvements in device
technology in the past years, there is still a
fairly high rate of adverse events (3,7).
These considerations demonstrate the
need for an effective risk-stratifying strat-
egy to identify patients who will most/
least likely benefit from this therapy. Non-
invasive risk stratification in this patient
population has achieved unsatisfactory re-
sults to date (2). In particular, the use of
left ventricular (LV) ejection fraction has
limitations, and relying on electrocardio-
gram provocation tests such as pro-
grammed ventricular stimulation in elec-
trophysiology studies (EPS) yielded controversial
results (8). One aspect that may show promise is to
target the focal substrate, that is, the infarct scar
initiating the arrhythmic cascade that leads to sudden
cardiac death. Currently, late gadolinium enhance-
ment cardiac magnetic resonance (LGE-CMR) is a
well-established and accurate method to assess scar
morphology in the clinical setting (9), and there are
Germany; ‡Medical University Berlin, Charité Campus Buch and Camp
Berlin, Charité Campus Buch and Campus Steglitz, Berlin, Germany; 
¶Cardioimaging Centre Berlin, Berlin, Germany; and the #Leiden Unive
Department of Radiology, Leiden, the Netherlands. This study was fund
Prof. Schulz-Menger. All authors have reported that they have no relations
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dy
)Manuscript received January 3, 2011; revised manuscript received March 16,first results describing its relation to inducible arrhyth-
mias (10). We hypothesized that infarct transmurality
assessed with LGE-CMR prior to ICD insertion
would independently predict life-threatening arrhyth-
mias in a cohort of patients with chronic myocardial
infarction and clinical characteristics similar to the
MADIT (Multicenter Automatic Defibrillator Im-
plantation Trial) study population (4,6).
M E T H O D S
Patients. This prospective study was conducted be-
ween May 2004 and August 2009 in a single tertiary
eferral center. All patients referred to our department
or ICD implantation between May 2004 and June
007 (n  140) were screened and consecutively
ncluded if they fulfilled primary prevention criteria for
udden cardiac death following MADIT I or II:
ocumented previous myocardial infarction (adapted
o current guidelines: more than 40 days of age [11]);
V ejection fraction, by non-CMR method, below
0% or LV ejection fraction below 35% and docu-
ented nonsustained ventricular tachycardia (VT) in
onjunction with a positive EPS. The screening pro-
edure is shown in Figure 1. Baseline study group
haracteristics are given in Table 1. All patients gave
nformed consent, and the study was approved by the
nstitutional ethics committee.
CMR protocol. Patients underwent a CMR study
using a 1.5-T clinical CMR system (Avanto or
Sonata, Siemens Healthcare, Erlangen, Germany) 36
78 days before ICD implantation. The imaging protocol
comprised state-of-the-art electrocardiogram-gated cine
steady-state free-precession acquisitions for the
analysis of cardiac dimensions and function in 2
long-axis planes as well as a stack of contiguous
short-axis slices (6-mm slice thickness) covering the
left ventricle from base to apex without gap (pa-
rameters: matrix 256  224, field of view 340 mm,
flip angle 75°, echo time 1.2 ms, repetition time 3
ms, and a temporal resolution of 30 ms). Approx-
imately 10 to 15 min after intravenous injection of
0.2 mmol/kg gadolinium diethylenetriamine penta-
acetate (Magnevist, Bayer Schering Pharma, Berlin,
Germany), late enhancement imaging was per-
irchow, Berlin, Germany; §Medical University
:SSiS Statistical Consulting, Berlin, Germany;
Medical Center, Division of Image Processing,
by personal institutional research grants held by
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resonance
EPS electrophysiology stu
IB(Z) infarct border (zone
ICD implantable
cardioverter/defibrillator
LGE late gadolinium
enhancement
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RIM relative infarct mass
RIT relative infarct
transmurality
ROC receiver-operator
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873formed in the same slice orientation as the cine
images using a standard 2-dimensional inversion-
recovery gradient-echo sequence. The inversion
time was manually adjusted to achieve optimal
suppression of signal from normal myocardium
(parameters: matrix 256  192, field of view 350 
262 mm, flip angle 30°, echo time 4.3 ms, repetition
time 500 ms, inversion time 250 to 300 ms).
CMR image post-processing and data analysis. Images
and data were analyzed by an experienced cardiol-
ogist blinded to clinical and electrophysiology data
using a research version of MASS (Leiden Univer-
sity Medical Center, the Netherlands). Left ven-
tricular dimensions and function were calculated
from the cine images. In LGE images, epicardial
and endocardial contours as well as a region of
interest (ROI) within remote myocardium were
traced manually in each slice. Images were analyzed
semiautomatically: areas of LGE were defined as a
signal intensity of more than 5 standard deviations
(SD) above remote myocardium as previously de-
scribed (12). Each slice was segmented in 100
chords starting from the anterior right ventricular
insertion point, and for each chord, the amount of
LGE was calculated as well as the amount of
Figure 1. Screening Strategy
ARVD  arrhythmogenic right ventricular cardiomyopathy; CAD 
hypertrophic cardiomyopathy; ICD  implantable cardioverter-deﬁb
cardiac death.transmural extent (above 75% wall thickness). Ad-ditionally, for each chord, the presence of an inter-
face between remote myocardium and LGE was
assessed, and if present, the corresponding surface
area was included in the infarct border (IB) (Figs. 2
and 3) calculation. Infarct border zone (IBZ) was
defined as areas with signal intensity of more than 2
or 3 SD above remote myocardium but below 3, 4,
or 5 SD and below 4 or 5 SD, respectively (reflect-
ing infarct core and heterogeneity, adapted from
previously described studies) (13,14). These mea-
surements resulted in 6 different border zone mea-
sures (Table 2).
The evaluated parameters included LV mass and
end-diastolic volume, calculation of LV ejection
fraction, infarcted mass, relative infarct mass (RIM:
percent of LV mass), the amount of transmurally
infarcted mass normalized to LV mass (infarct
transmurality) and normalized to total infarct mass
(RIT). To further evaluate infarct morphology, IB
(mm2) and IBZ (g) were calculated as described in
the previous text (Figs. 2 and 3).
ICD implantation and clinical follow-up. All ICDs
were programmed in a standardized fashion. De-
tection criteria for VT and ventricular fibrillation
were as follows: VT was considered if 12 of 16
nary artery disease; DCM  dilated cardiomyopathy; HCM 
tor; MR  magnetic resonance; pat  patients; SCD  suddencoro
rillaconsecutive heart beats were at a heart rate within
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874176 and 201 beats per minute (beats/min). Ventric-
ular fibrillation was considered if 8 of 12 consecu-
tive heart beats were at a heart rate of at least 202
beats/min. After ICD implantation, patients were
followed up, including ICD interrogation, after 3
months and then every 6 months or as clinically
indicated. The primary endpoint of the study was
the occurrence of an appropriate discharge, anti-
tachycardia pacing, or death from cardiac cause.
Data were analyzed by an experienced electrophysi-
ologist blinded to the CMR results.
Statistical analysis. The analysis was performed us-
ng SPSS version 14.0 (SPSS Inc., Chicago, Illi-
ois) and SAS version 9.2 (SAS Institute, Cary,
orth Carolina). Continuous variables are ex-
ressed as mean  SD. Baseline characteristics
ere compared between patients that reached the
ndpoint and those that did not using Fisher exact
est for categorical and Mann-Whitney U test for
ontinuous variables. The evaluation of potential
redictors for life-threatening ventricular arrhyth-
Characteristics
With Event
(n  16)
Without Event
(n  36) p Value
73 10 69 10 0.28
kg/m2 27 3 27 4 0.36
s 117 79 80 73 0.19
lass 0.95*
2 5
10 22
4 9
0 0
13 (81%) 33 (92%) 0.36
ia 13 (81%) 27(75%) 0.73
6 (38%) 17 (47%) 0.56
1(6%) 7 (19%) 0.41
15 (94%) 35(97%) 0.52
16 (100%) 35(97%) 1.00
14 (88%) 34 (94%) 0.58
3 (19%) 6(17%) 1.00
hmic agent 1 (6%) 3 (17%) 1.00
13 (81%) 23(64%) 0.33
131 35 112 27 0.14
ch block 5 (31%) 5 (14%) 0.25
anch block 3 (19%) 4 (11%) 0.66
6 (38%) 5 (14%) 0.07
, n, or n (%). The Fisher exact test for categorical and Mann-Whitney U test for
ere used. *Mann-Whitney U test on differences in NYHA functional classes.
onverting enzyme; NYHA  New York Heart Association.ia and cardiac mortality was performed usingultiple separate logistic regression models. The
ollowing variables were tested: age, LV ejection
raction, LV end-diastolic volume, LV mass, total
nfarct mass and RIM, parameters of infarct mor-
hology (IB, IBZ, infarct transmurality, RIT), and
ll baseline clinical characteristics. The variables
ere tested in separate models with RIT as a second
xplaining factor to select only variables in the final
odel that add significantly to the RIT. Receiver-
perator characteristic (ROC) analysis was per-
ormed on significant predictors to calculate the
ccuracy and other diagnostic parameters and to
etermine a cutoff point at the maximum sum of
ensitivity and specificity using the Youden index.
lopper-Pearson 95% confidence intervals were cal-
ulated for the diagnostic parameters. The 95% con-
dence interval for the area under the ROC curve
as calculated by bootstrapping. Kaplan-Meier
urves were calculated for the RIT to evaluate the
erformance of the predictor on the primary end-
oint. Two-sided p values 0.05 were regarded as
tatistically significant.
R E S U L T S
Baseline characteristics. Fifty-two patients were en-
olled in the present study. Their baseline charac-
eristics are shown in Table 1, and the screening/
nclusion strategy is illustrated in Figure 1. Medical
herapies at baseline and basic risk factors were not
ifferent between patients who did or did not meet
he combined endpoint (Table 1).
Electrophysiological and mortality data. The mean
follow-up was 1,235  341 days. Endpoint criteria
were met in 16 patients, resulting in an annual event
rate of 4.7%. Events occurred 714  382 (70 to
1,516) days after ICD placement. Six patients
received an appropriate shock, 7 patients received
recurrent appropriate antitachycardia pacing for
sustained VT, and 3 patients died of cardiac cause
(2 patients died of advanced heart failure in hospi-
tal, 1 patient of presumable sudden cardiac death at
home during sleep). All 6 patients with ICD shocks
as well as 2 patients with an episode of antitachy-
cardia pacing presented to the emergency room
within 1 week after the event. In these patients,
acute myocardial infarction as a trigger for arrhyth-
mic events was ruled out by electrocardiogram and
negative troponin levels. The remaining 5 patients
with antitachycardia pacing presented to our out-
patient clinic more than 1 week after the events and
did not report episodes of acute chest pain orTable 1. Baseline
Clinical data
Age, yrs
Body mass index,
Infarct age, month
NYHA functional c
I
II
III
IV
Hypertension
Hypercholesterolem
Diabetes
Current smoker
Medication
Beta-blocker
ACE inhibitor
Statin
Amiodarone
Other antiarrhyt
Diuretics
Electrocardiogram
QRS duration, ms
Left bundle bran
Right bundle br
Atrial ﬁbrillation
Values are mean  SD
continuous variables wdyspnea.
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875CMR data. The baseline CMR values of the study
population were as follows: mean LV mass 153 
39 g; LV end-diastolic volume 274  93 ml; and
mean LV ejection fraction 30  9%. LGE was
observed in all patients included in the study with a
mean infarct mass of 39  21 g.
LGE extent and primary endpoint. Analysis of the
CMR data showed that RIM, infarct transmurality,
and RIT were significantly associated with the
endpoint (p  0.02 each) (Table 2). All other
parameters showed no significant association with
the endpoint criteria, including LV ejection frac-
tion, LV mass, LV end-diastolic volume, infarct
mass, IB, and IBZ defined as areas of moderately
increased signal (Table 2).
In separate multiple logistic regression models of
RIT with one of the effects LV ejection fraction,
LV mass, LV end-diastolic volume, infarct mass,
RIM, IB, IBZ, infarct transmurality, RIT, and all
baseline characteristics, only RIT alone emerged as
an independent predictor of the primary endpoint
(p  0.02). The odds ratio for RIT was 22.1 (95%
confidence limits: 1.64 to 297.58). ROC analysis of
RIT as a predictor for events (arrhythmic events
and cardiac mortality) showed an area under the
curve of 0.70 (95% confidence interval [CI]: 54% to
85%), that is, an accuracy of 70%. A cutoff at 43%
for the RIT resulted in a sensitivity of 88% (14 of
16, 95% CI: 61% to 98%), a specificity of 50% (18
of 36, 95% CI: 33% to 67%), a positive predictive
value of 44% (14 of 32, 95% CI: 26% to 62%), and
a negative predictive value of 90% (18 of 20, 95%
CI: 68% to 99%).
Using this cutoff, the study population was di-
vided into 2 groups (43% and 43% RIT), and a
aplan-Meier curve for event-free survival was
alculated (Fig. 4). Only 2 of 16 (12%) patients in
he group with less than 43% RIT showed an event
ompared with 14 of 16 (88%) in the group with
43% RIT (p  0.04). Separating the study popu-
ation by LV ejection fraction (LV ejection fraction
30% vs. 30% to 35%) showed no significant differ-
nce between the MADIT populations (LV ejection
raction 30%: 25 patients total, 17 patients with no
vent, 8 patients with an event; LV ejection fraction
0% to 35%: 27 patients total, 19 no event, 8 with an
vent; Fisher exact test p  1.00).
D I S C U S S I O N
The main result of our prospective study is that RIT
seems to be a strong predictor for a composite
endpoint of spontaneous life-threatening ventricu-lar arrhythmias and cardiac mortality in chronic
infarct patients scheduled for primary preventive
ICD implantation. This finding was found to be
independent of each of the established markers of
adverse outcome like LV ejection fraction, LV
end-diastolic volume, total infarct mass and RIM,
and age as tested in separate logistic regression
models and may therefore have implications for the
risk stratification of chronic infarct patients. The
limited sample size, however, did allow for testing
RIT with only 1 other potential marker in a single
model so we could not evaluate combinations of
RIT with more than 1 other potential marker.
Several studies have documented a survival ben-
efit with primary preventive implantation of ICD in
heart failure patients, using LV ejection fraction as
a determinant for risk stratification (4–6). There-
fore, LV ejection fraction has become a major
criterion for prophylactic ICD implantation despite
being a poor indicator of treatment benefit. Re-
cently, there is increased interest in characterizing
infarct scar morphology as a potential candidate for
better risk stratification strategies. Phenomena such
as re-entry or distortion of intramyocardial sympa-
thetic innervation play a key role in post-infarct
arrhythmogenesis and are substantially affected by
scar morphology (15). Specifically, earlier studies
demonstrated a close relationship between scar size
or transmural involvement and the risk of arrhyth-
mia in animal models of myocardial infarction (16).
LGE-CMR allows precise assessment of myocar-
dial scar morphology with an accuracy matching
Table 2. Analysis of CMR Parameters as Predictors of the Study
With Event
(n  16)
Without Eve
(n  36)
LV ejection fraction, % 28 6 30 8
LV end-diastolic volume, ml 286 123 271 78
LV mass, g 152 27 154 45
Infarct mass, g 46 22 35 20
RIM, % of LV mass 30 14 21 11
Infarct border, mm2 950 404 952 496
IBZ, g (LGE: 2–3 SD) 7.9 2.2 8.6 1.7
IBZ, g (LGE: 2–4 SD) 13.8 4.2 13.6 4.8
IBZ, g (LGE: 2–5 SD) 17.4 5.1 19.2 4.0
IBZ, g (LGE: 3–4 SD) 5.9 2.3 5.4 3.3
IBZ, g (LGE: 3–5 SD) 9.6 3.1 10.6 4.6
IBZ, g (LGE: 4–5 SD) 3.7 1.6 5.1 4.3
Infarct transmurality, g 21 13 12 10
RIT, % of infarct mass 64 26 43 26
Values are mean  SD. *p  0.05.
CMR  cardiac magnetic resonance; LGE  late gadolinium enhancement; LV 
infarct border zone; RIM  relative infarct mass; RIT  relative infarct transmuralitEndpoint
nt
p Value
0.31
0.61
0.84
0.09
0.02*
0.99
0.23
0.93
0.23
0.66
0.52
0.28
0.02*
0.01*
left ventricular; IBZ that of histopathology (17,18). Additionally, LGE-
anc
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876CMR is of increasing importance for risk stratifi-
cation in cardiomyopathies (19) as well as coronary
artery disease (20). Recently, LGE-CMR was
shown as the strongest predictor of all-cause mor-
tality in a large retrospective setting (21). In chronic
myocardial infarction, infarct morphology as de-
fined by LGE-CMR was also shown to be associ-
ated with inducibility of sustained VT in humans
(10,13,22) as well as in animal models (23). Spe-
cifically, Bello et al. (10) found that infarct mass and
IB size were better predictors of inducibility of VT
in EPS than LV ejection fraction. However, induc-
ibility of VT in EPS is only a surrogate parameter
and seems to be of limited use in the prediction of
Figure 2. Scheme of LGE Assessment in Short-Axis Orientation
(A,B) Segmentation into chords, calculation of infarct mass, relative
rality (RIT). Calculations: RIT  transmural infarct mass (yellow) in g
(grams)/myocardial mass (grams). (C) Infarct border: interface betwe
zone (green region of interest) calculated from different standard d
myocardium, dark grey the infarct core. LGE  late gadolinium enh
Figure 3. Assessment of LGE Parameters
(A) Typical end-diastolic mid-cavity LGE images of 2 patients with p
low (2) RIT (overall RIT: Patient #1  76%, Patient #2  30%; LV eje
sustained ventricular tachycardia terminated by ICD 121 days after
signal intensity (SI) greater than average SI 5 SD of remote myoc
wall thickness. Green contour indicates epicardial circumference, re
remote myocardium, and green ROI  5 SD. (C) Segmentation int
est; other abbreviations as in Figures 1 and 2.spontaneous VT, especially in patients meeting the
MADIT criteria (24).
There is increasing interest in infarct tissue het-
erogeneity, specifically infarct border zone assess-
ment, as a potential origin of arrhythmic triggers.
Several studies showed an association between IBZ
size and inducibility of ventricular arrhythmias in
EPS (13,22), and recently, it was shown that
LGE-driven infarct tissue heterogeneity is associ-
ated with spontaneous ventricular arrhythmias in
patients after myocardial infarction (25). Unfortu-
nately, infarct tissue heterogeneity and border zone
suffers from different definitions today, making
direct comparisons difficult. Some investigators use
rct mass (RIM), infarct transmurality, and relative infarct transmu-
s/total infarct mass (dark grey) in grams; RIM  infarct mass
infarcted and remote myocardium (red line). (D) Infarct border
tions above remote myocardium. Light grey indicates the remote
ement.
ous myocardial infarction (bright region) showing high (1) and
n fraction: Patient #1  29%, Patient #2  21%; Patient #1 had
lantation). (B) Semiautomated quantiﬁcation of LGE deﬁned as
m. Transmural involvement is deﬁned as LGE-extent 75% of
ntour indicates endocardial circumference, blue ROI indicates
0 chords (yellow lines). LV  left ventricular; ROI  region of inter-infa
ram
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eviarevi
ctio
imp
ardiu
d co
o 10
a
t
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 8 , 2 0 1 1
A U G U S T 2 0 1 1 : 8 7 1 – 9
Boyé et al.
Arrhythmia Prediction by CMR
877the full-width half-maximum approach to define
infarct core and periphery, whereas others defined
infarct core and periphery according to differences
in SD above remote myocardium using different
cutoff values (13,14,22,25). In the present study, we
did not find a significant association between any of
our infarct periphery measures and the occurrence
of the combined endpoint. This may be a result of
population differences, as we strictly focused on
patients matching MADIT criteria as well as dif-
ferences in LGE-CMR assessment. Specifically, we
used a thin-slice thickness, which could have lead to
less partial volume effects with a more precise IB
definition and therefore to fundamental differences
in IBZ assessment.
Kelle et al. (26) found total infarct size to be a
strong predictor of future events in coronary artery
disease patients with positive LGE-CMR. These
data are consistent with our findings that RIM is a
predictor of the composite endpoint of spontaneous
VT and death in univariate analysis. Interestingly,
the authors did not find an association between
infarct transmurality and cardiac events as presented
in this study. This may be due to differences in the
study populations (consecutive LGE-positive coro-
nary artery disease patients with a mean LV ejection
fraction of 45% vs. “MADIT patients” with a mean
LV ejection fraction of 30% in our population) and
due to methodological disparities in LGE assess-
ment. A recent study by Desjardins et al. (17) fused
Figure 4. Kaplan-Meier Analysis Showing the Differences in Eve
The patient population was divided according to a relative infarct t
curve analysis).electroanatomic mapping results with CMR images ein post-infarct patients with recurrent ventricular
arrhythmia and showed that VT circuits are mainly
located in the center of the LGE-CMR–defined
infarcts. Even in cases with VT circuit detection in
infarct periphery, these patients had mainly trans-
mural infarct extensions (17), and electric instability
was particularly increased in scar regions with a
high transmural involvement and large infarct cores
(17). These findings match former studies that
found an association between infarct transmurality
and ventricular arrhythmias in animal models of
myocardial infarction (16,27) and our results show-
ing that infarct transmurality is associated with
life-threatening arrhythmias and mortality in post-
infarct patients. Taken together, these different
findings, including the present study, indicate it
might not be infarct size that causes vulnerability to
cardiac arrhythmia but rather the transmural infarct
extension with alteration of sympathetic cardiac
innervation. Large infarction with consecutively
severely reduced ejection fraction are associated
with increased mortality from cardiac arrhythmia,
but considering the previously stated findings, this
might only reflect a higher proportion of transmu-
rally infarcted tissue, and transmurality might be
the more promising parameter for adequate risk
assessment in post-myocardial infarction patients.
Study limitations. The present study was conducted
t a single center with a relatively small sample size;
he number of events was small, so that only strong
ree Survival
murality (RIT) cutoff value of 43% (derived from receiver-operatornt-F
ransffects can be detected besides effects that show
W
l
N
b
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878significance by chance only. The statistical power
with regard to confirmative statistical testing was
low. These results should therefore be interpreted
with care and can only be regarded as a pilot study
to provide basic data for the adequate planning of a
confirmatory sufficiently powered multicenter
study. This would also enable the verification and
validation of the value of RIT as a biomarker, the
cutoff point, and the performance of the presented
marker on an independent dataset.
C O N C L U S I O N S
The extent of transmural scar formation, as assessed
with LGE-CMR, seems to be a predictor of the
composite endpoint of spontaneous life-threatening
arrhythmias and cardiac death in post-infarct pa-disease at high risk for ventricular
1
1
1
vasc Magn Reson 2plantation. This finding needs to be confirmed by a
larger multicenter clinical study.
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